Third Harmonic Bio Inc (NASDAQ: THRD) is -43.73% lower on its value in year-to-date trading and has touched a low of $5.64 and a high of $16.94 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The THRD stock was last observed hovering at around $5.68 in the last trading session, with the day’s gains setting it 0.11%.
Currently trading at $5.79, the stock is -38.65% and -48.60% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.23 million and changing 1.94% at the moment leaves the stock -52.64% off its SMA200. THRD registered -43.29% loss for a year compared to 6-month loss of -51.79%. The firm has a 50-day simple moving average (SMA 50) of $11.2644 and a 200-day simple moving average (SMA200) of $12.226675.
The stock witnessed a -47.93% gain in the last 1 month and extending the period to 3 months gives it a -57.64%, and is -30.66% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.02% over the week and 10.22% over the month.
Third Harmonic Bio Inc (THRD) has around 30 employees, a market worth around $260.89M and $0.00M in sales. Distance from 52-week low is 2.66% and -65.82% from its 52-week high. The company has generated returns on investments over the last 12 months (-13.18%).
The EPS is expected to shrink by -47.95% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Third Harmonic Bio Inc (THRD) Top Institutional Holders
116.0 institutions hold shares in Third Harmonic Bio Inc (THRD), with institutional investors hold 101.54% of the company’s shares. The shares outstanding are 44.73M, and float is at 17.43M with Short Float at 20.60%. Institutions hold 92.36% of the Float.
The top institutional shareholder in the company is ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC with over 10.91 million shares valued at $141.8 million. The investor’s holdings represent 26.8961% of the THRD Shares outstanding. As of 2024-06-30, the second largest holder is ORBIMED ADVISORS LLC with 5.78 million shares valued at $75.13 million to account for 14.2498 of the shares outstanding. The other top investors are BVF INC/IL which holds 4.37 million shares representing 10.7653% and valued at over $56.76 million, while ECOR1 CAPITAL, LLC holds 7.8471 of the shares totaling 3.18 million with a market value of $41.37 million.
Third Harmonic Bio Inc (THRD) Insider Activity
The most recent transaction is an insider sale by Conner Edward R., the company’s Chief Medical Officer. SEC filings show that Conner Edward R. sold 2,117 shares of the company’s common stock on Nov 08 ’24 at a price of $15.00 per share for a total of $31755.0. Following the sale, the insider now owns 0.0 shares.
Third Harmonic Bio Inc disclosed in a document filed with the SEC on Oct 29 ’24 that BVF PARTNERS L P/IL (See Explanation of Responses) sold a total of 1,000,000 shares of the company’s common stock. The trade occurred on Oct 29 ’24 and was made at $14.30 per share for $14.3 million. Following the transaction, the insider now directly holds 0.18 million shares of the THRD stock.
Still, SEC filings show that on Oct 28 ’24, Conner Edward R. (Chief Medical Officer) disposed off 2,673 shares at an average price of $15.00 for $40095.0. The insider now directly holds 0 shares of Third Harmonic Bio Inc (THRD).
